Symbiosis Pharmaceutical Services, a global CMO specializing in the sterile manufacture of injectable drug products, has strengthened its business development team in the U.S. with the appointments of Kevin O’Brien and LeeAnn Nguyen as Vice Presidents of Business Development for North America, and North America and Asia, respectively. 

Kevin O’Brien

With over 30 years of experience in the pharmaceutical industry, Kevin brings extensive experience in client development and a strong technical background. Prior to joining Symbiosis, he served as Vice President of Business Development at Siegfried, representing multiple drug manufacturing sites. Based in California, Kevin’s focus will be to drive client growth and promote awareness of Symbiosis’ specialist sterile manufacturing capabilities across North America. 

LeeAnn Nguyen

LeeAnn Nguyen joins the company with more than 15 years of experience in the life sciences industry. Most recently, LeeAnn was Director of Business Development at Ajinomoto Biopharma Services where she focused on supporting clients through complex sterile manufacturing programs. Based in Raleigh, North Carolina, LeeAnn will focus on securing new clinical and commercial partnerships and positioning Symbiosis as a trusted partner for companies seeking accelerated project timelines. 

Colin MacKay, Chief Executive Officer at Symbiosis, said, “We’re delighted to welcome Kevin and LeeAnn to the Symbiosis team at what is an exciting time for the company. With our recently expanded manufacturing capacity, their extensive experience, client focus, and strong networks in the North American and Asian markets will be instrumental in Symbiosis continued global expansion. These appointments reinforce the company’s ongoing commitment to providing fast, flexible, high-quality sterile manufacturing solutions for our clients.”